Author:
Chopra Asmita,Hodges Jacob C.,Olson Adam,Burton Steve,Ellsworth Susannah G.,Bahary Nathan,Singhi Aatur D.,Boone Brian A.,Beane Joal D.,Bartlett David,Lee Kenneth K.,Hogg Melissa E.,Lotze Michael T.,Paniccia Alessandro,Zeh Herbert,Zureikat Amer H.
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol. 2019;10(1):10–27. https://doi.org/10.14740/wjon1166.
2. Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975–2016, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2016/, based on November 2018 SEER data submission, posted to the SEER web site, April 2019.
3. Nagakawa Y, Sahara Y, Hosokawa Y et al. Clinical impact of neoadjuvant chemotherapy and chemoradiotherapy in borderline resectable pancreatic cancer: analysis of 884 patients at facilities specializing in pancreatic surgery. Ann Surg Oncol. 2019;26(6):1629–36. https://doi.org/10.1245/s10434-018-07131-8.
4. Youngwirth LM, Nussbaum DP, Thomas S et al. Nationwide trends and outcomes associated with neoadjuvant therapy in pancreatic cancer: an analysis of 18243 patients. J Surg Oncol. 2017;116(2):127–32. https://doi.org/10.1002/jso.24630.
5. Zhan HX, Xu JW, Wu D et al. Neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of prospective studies. Cancer Med. 2017;6(6):1201–19. https://doi.org/10.1002/cam4.1071.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献